$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000088559017000015 Filed on March 01, 2017

Income Statement

Concept	2015 Q4	2015 Q3	2015 Q2
Revenue	$2.758B	$2.787B	$2.733B
YoY Change	23.38%	36.4%	33.9%
Cost Of Revenue	$676.7M	$634.6M	$669.9M
YoY Change	18.45%	16.27%	17.61%
Gross Profit	$2.060B	$2.152B	$2.063B
YoY Change	24.74%	43.73%	40.2%
Gross Profit Margin	74.68%	77.23%	75.49%
Selling, General & Admin	$742.9M	$697.6M	$685.5M
YoY Change	41.64%	38.39%	32.93%
% of Gross Profit	36.07%	32.41%	33.23%
Research & Development	$95.90M	$101.6M	$81.10M
YoY Change	62.27%	71.91%	21.95%
% of Gross Profit	4.66%	4.72%	3.93%
Depreciation & Amortization	$698.6M	$726.4M	$635.0M
YoY Change	90.93%	65.35%	55.75%
% of Gross Profit	33.92%	33.75%	30.78%
Operating Expenses	$1.670B	$799.2M	$766.6M
YoY Change	62.57%	41.9%	31.67%
Operating Profit	$168.0M	$448.0M	$342.0M
YoY Change	-72.79%	-33.29%	-3.69%
Interest Expense	-$435.0M	-$453.5M	-$406.2M
YoY Change	2303.31%	47.62%	73.52%
% of Operating Profit	-258.93%	-101.23%	-118.77%
Other Income/Expense, Net
YoY Change
Pretax Income	-$240.3M	-$5.700M	-$64.70M
YoY Change	-143.6%	-101.51%	-153.47%
Income Tax	$122.1M	-$57.40M	-$13.10M
% Of Pretax Income
Net Earnings	-$361.9M	$51.70M	-$51.60M
YoY Change	-172.08%	-81.3%	-142.3%
Net Earnings / Revenue	-13.12%	1.86%	-1.89%
Basic Earnings Per Share	-$1.12	$0.14	-$0.15
Diluted Earnings Per Share	-$1.12	$0.14	-$0.15
COMMON SHARES
Basic Shares Outstanding	343.1M shares	344.9M shares	344.4M shares
Diluted Shares Outstanding		351.0M shares	344.4M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$597.0M	$1.420B	$958.0M
YoY Change	84.83%	75.53%	80.41%
Cash & Equivalents	$597.0M	$1.420B	$958.0M
Short-Term Investments
Other Short-Term Assets	$966.0M	$1.680B	$1.786B
YoY Change	14.45%	112.12%	-6.98%
Inventory	$1.257B	$1.199B	$1.230B
Prepaid Expenses
Receivables	$2.687B	$2.696B	$2.371B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.507B	$6.996B	$6.345B
YoY Change	33.29%	58.5%	22.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.442B	$1.351B	$1.360B
YoY Change	9.88%	3.92%	3.05%
Goodwill	$18.55B	$17.37B	$17.23B
YoY Change	98.19%	83.51%	82.63%
Intangibles	$23.08B	$22.38B	$23.15B
YoY Change	104.67%	92.61%	97.0%
Long-Term Investments
YoY Change
Other Assets	$224.0M	$236.1M	$167.0M
YoY Change	33.81%	1.16%	-19.05%
Total Long-Term Assets	$43.46B	$41.46B	$42.00B
YoY Change	96.0%	83.07%	84.75%
TOTAL ASSETS
Total Short-Term Assets	$5.507B	$6.996B	$6.345B
Total Long-Term Assets	$43.46B	$41.46B	$42.00B
Total Assets	$48.97B	$48.45B	$48.34B
YoY Change	86.15%	79.07%	73.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$434.0M	$476.8M	$415.8M
YoY Change	9.05%	47.48%	26.88%
Accrued Expenses	$3.859B	$3.294B	$3.055B
YoY Change	78.91%	65.18%	72.11%
Deferred Revenue
YoY Change
Short-Term Debt	$16.00M	$0.00	$0.00
YoY Change	158.06%
Long-Term Debt Due	$823.0M	$707.0M	$590.9M
YoY Change	91344.44%	2.37%	121.56%
Total Short-Term Liabilities	$5.313B	$4.651B	$4.291B
YoY Change	96.17%	47.95%	71.89%
LONG-TERM LIABILITIES
Long-Term Debt	$30.27B	$30.18B	$30.29B
YoY Change	98.75%	93.63%	77.56%
Other Long-Term Liabilities	$185.0M	$209.1M	$208.8M
YoY Change	-6.14%	0.24%	-2.88%
Total Long-Term Liabilities	$30.45B	$30.39B	$30.50B
YoY Change	97.41%	92.4%	76.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.313B	$4.651B	$4.291B
Total Long-Term Liabilities	$30.45B	$30.39B	$30.50B
Total Liabilities	$42.94B	$41.99B	$41.78B
YoY Change	105.41%	92.38%	85.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.750B	-$2.339B	-$2.388B
YoY Change	14.69%	-19.36%	-24.8%
Common Stock	$10.20B	$10.14B	$10.11B
YoY Change	18.72%	18.31%	18.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.910B	$6.342B	$6.435B
YoY Change
Total Liabilities & Shareholders Equity	$48.97B	$48.45B	$48.34B
YoY Change	86.15%	79.07%	73.3%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2015 Q2
OPERATING ACTIVITIES
Net Income	-$361.9M	$51.70M	-$51.60M
YoY Change	-172.08%	-81.3%	-142.3%
Depreciation, Depletion And Amortization	$698.6M	$726.4M	$635.0M
YoY Change	90.93%	65.35%	55.75%
Cash From Operating Activities	$598.0M	$733.0M	$418.0M
YoY Change	-26.69%	18.47%	11.17%
INVESTING ACTIVITIES
Capital Expenditures	-$81.20M	$51.10M	$46.80M
YoY Change	-47.27%	29.04%	-58.77%
Acquisitions		$115.8M	$13.09B
YoY Change		-80.92%	19151.32%
Other Investing Activities	-$1.454B	-$105.0M	$500.0K
YoY Change	2706.76%	-112.07%	-135.71%
Cash From Investing Activities	-$1.535B	-$156.2M	-$2.645B
YoY Change	645.92%	-120.65%	892.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$50.00M
YoY Change
Debt Paid & Issued, Net		$29.00M	$247.9M
YoY Change		-98.22%	106.07%
Cash From Financing Activities	122.5M	-$108.5M	$1.325B
YoY Change	-111.15%	-89.97%	-946.3%
NET CHANGE
Cash From Operating Activities	$598.0M	$733.0M	$418.0M
Cash From Investing Activities	-1.535B	-$156.2M	-$2.645B
Cash From Financing Activities	122.5M	-$108.5M	$1.325B
Net Change In Cash	$598.0M	$468.3M	-$901.9M
YoY Change	-26.69%	59.88%	1818.94%
FREE CASH FLOW
Cash From Operating Activities	$598.0M	$733.0M	$418.0M
Capital Expenditures	-$81.20M	$51.10M	$46.80M
Free Cash Flow	$679.2M	$681.9M	$371.2M
YoY Change	-29.96%	17.75%	41.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	347839513	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	53000000	USD
CY2016	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	5979817000	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	Valeant Pharmaceuticals International, Inc.
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	434000000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	324000000	USD
CY2015Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	77000000	USD
CY2016Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	50000000	USD
CY2015Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	243000000	USD
CY2016Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	198000000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	221000000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	213000000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3859000000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3175000000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	93000000	USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	84000000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	69000000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1184000000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1196000000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1542000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2108000000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	305000000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	351000000	USD
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-44000000	USD
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-88000000	USD
CY2016	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-11000000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78000000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	140000000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165000000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	17000000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	57000000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	435000000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	652000000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	564000000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	67000000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	80000000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	70000000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	145000000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	118000000	USD
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges	145000000	USD
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	304000000	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	422000000	USD
CY2015Q4	us-gaap	Assets Assets	48965000000	USD
CY2016Q4	us-gaap	Assets Assets	43529000000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	5507000000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	5077000000	USD
CY2015Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3000000	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	261000000	USD
CY2014	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.09
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.80
CY2014	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-1.09
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-1.80
CY2014	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-375000000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-619000000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10248000000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10710000000	USD
CY2014	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6000000	USD
CY2015	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	39000000	USD
CY2016	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2000000	USD
CY2014	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-11000000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-23000000	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-28000000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	516000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	18000000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	197000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	52000000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	959000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	840000000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	26000000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	3000000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	4000000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	3000000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	3000000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	4000000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	9000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	597000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	542000000	USD
CY2014	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2015	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2016	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	30000000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	174000000	USD
CY2015Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2016Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	347821606	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	342926531	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	342926531	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	347821606	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	9897000000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	10038000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	98000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-918000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2975000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	95000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-918000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2979000000	USD
CY2016Q4	us-gaap	Contractual Obligation ContractualObligation	65000000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2178000000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2532000000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2572000000	USD
CY2014	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	58000000	USD
CY2015	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	53000000	USD
CY2016	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	39000000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	6205000000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	1600000000	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	2391000000	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	2339000000	USD
CY2015Q4	us-gaap	Costs And Expenses CostsAndExpenses	2590000000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	8920000000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	2306000000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	2339000000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	3343000000	USD
CY2016Q4	us-gaap	Costs And Expenses CostsAndExpenses	2252000000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	10240000000	USD
CY2015Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	30000000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1000000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	150000000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	77000000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	241000000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	151000000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	77000000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	241000000	USD
CY2015Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	31437000000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	30169000000	USD
CY2015	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2016	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	2436000000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	323000000	USD
CY2014	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2016	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-18000000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3000000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	23000000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	59000000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-268000000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23000000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	56000000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-268000000	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7501000000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6369000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	15000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3120000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2938000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1754000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1081000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	156000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	146000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	295000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	422000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	68000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	37000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	594000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	563000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1366000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1857000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5747000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5288000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4711000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4044000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5903000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5434000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	71000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	56000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	17000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	26000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	2607000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	2165000000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	21000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	28000000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	28000000	USD
CY2014	us-gaap	Depreciation Depreciation	187000000	USD
CY2015	us-gaap	Depreciation Depreciation	210000000	USD
CY2016	us-gaap	Depreciation Depreciation	193000000	USD
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1614000000	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2467000000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2866000000	USD
CY2015Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	2132000000	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.63
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.49
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.94
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.58
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.49
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.47
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.94
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-29000000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-30000000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-54000000	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	17000000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	57000000	USD
CY2014	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	398000000	USD
CY2015Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2016Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-23000000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-13000000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-1000000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-40000000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	1010000000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	175000000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	348000000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1156000000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	892000000	USD
CY2016	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7412000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9435000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5958000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2509000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1900000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1995000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2176000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2395000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28187000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	26368000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20775000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16933000000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-144000000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-103000000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-41000000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-135000000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-95000000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-14000000	USD
CY2014	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	284000000	USD
CY2015	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-42000000	USD
CY2016	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-655000000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	254000000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5000000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	8000000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	251000000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-8000000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	6000000	USD
CY2014	us-gaap	Gain Loss On Investments GainLossOnInvestments	293000000	USD
CY2015	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2016	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	45000000	USD
CY2015	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-37000000	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-59000000	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-94000000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-130000000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q4	us-gaap	Goodwill Goodwill	9361000000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	18553000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	15794000000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	9463000000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1000000	USD
CY2015	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-308000000	USD
CY2014Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1077000000	USD
CY2016	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	0	USD
CY2015	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	37000000	USD
CY2016	us-gaap	Goodwill Transfers GoodwillTransfers	-1378000000	USD
CY2016	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	5000000	USD
CY2016Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	215000000	USD
CY2016Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	142000000	USD
CY2016Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	38000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-851000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1516000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1804000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1905000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1361000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-631000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1054000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-155000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2435000000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	174000000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	133000000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-27000000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	255000000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	230000000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	472000000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	30000000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2014	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	33000000	USD
CY2015	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	87000000	USD
CY2016	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	147000000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-230000000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-350000000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-290000000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	377000000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	20000000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4000000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4000000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	50000000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	30000000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2000000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	99000000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	95000000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	149000000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	318000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	325000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-144000000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	572000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	626000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34000000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	193000000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	276000000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	164000000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	110000000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	91000000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-232000000	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	5000000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6100000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	30495000000	USD
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	28319000000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23083000000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18884000000	USD
CY2014	us-gaap	Interest And Debt Expense InterestAndDebtExpense	971000000	USD
CY2015	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1563000000	USD
CY2016	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1836000000	USD
CY2014	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	7000000	USD
CY2015	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	14000000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	24000000	USD
CY2014	us-gaap	Interest Paid InterestPaid	934000000	USD
CY2015	us-gaap	Interest Paid InterestPaid	1269000000	USD
CY2016	us-gaap	Interest Paid InterestPaid	1718000000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	328000000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	337000000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	815000000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	680000000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	1257000000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	1061000000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	289000000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	256000000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	153000000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	125000000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	8000000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	42936000000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	40271000000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48965000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43529000000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5313000000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3609000000	USD
CY2015Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	57000000	USD
CY2015Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	57000000	USD
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	7000000	USD
CY2016Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	120000000	USD
CY2016Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	184000000	USD
CY2015Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	12000000	USD
CY2016Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	7000000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	31088000000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	29846000000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	823000000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1000000	USD
CY2015Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	29597000000	USD
CY2016Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	26297000000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	13371000000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3215000000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7723000000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2122000000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3738000000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	30265000000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29845000000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	119000000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	106000000	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2000000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8000000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9000000	USD
CY2014	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	3000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-277000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	274000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-55000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2460000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13624000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1963000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15577000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2312000000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	509000000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	418000000	USD
CY2015Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	733000000	USD
CY2015Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	598000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2257000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	556000000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	449000000	USD
CY2016Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	569000000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	513000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2087000000	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	881000000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	97000000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-53000000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	49000000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-385000000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-292000000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-374000000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-302000000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1218000000	USD
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-515000000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2409000000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	11000000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	3129000000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2014	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	15000000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	5000000	USD
CY2015Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1442000000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1312000000	USD
CY2016	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	1	business
CY2016Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2000	segment
CY2016Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2016	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	2001000000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	569000000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	342000000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-864000000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	448000000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	168000000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	1527000000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	66000000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	81000000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	151000000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-566000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	440000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	87000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	36000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	45000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	58000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	67000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	147000000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	75000000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	85000000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	84000000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	278000000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	178000000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	224000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	184000000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-29000000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-6000000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-127000000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	21000000	USD
CY2016	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-32000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-3000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-3000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-3000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-718000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-647000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-548000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-5000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-785000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-630000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-571000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	67000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-17000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	23000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	28000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-3000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	4000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	2000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2000000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	185000000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107000000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-32000000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	10000000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-8000000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	263000000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-295000000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-73000000	USD
CY2014	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	0	USD
CY2015	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	26000000	USD
CY2016	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	0	USD
CY2014	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	3000000	USD
CY2015	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	33000000	USD
CY2016	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	69000000	USD
CY2014	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	106000000	USD
CY2015	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	151000000	USD
CY2016	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	123000000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	72000000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	52000000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	103000000	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	97000000	USD
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	18000000	USD
CY2014	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	44000000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	88000000	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1102000000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15458000000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	19000000	USD
CY2014	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	76000000	USD
CY2015	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2016	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	179000000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	68000000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	56000000	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	72000000	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	49000000	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1000000	USD
CY2014	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	292000000	USD
CY2015	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	235000000	USD
CY2016	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	235000000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	292000000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235000000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235000000	USD
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	8000000	USD
CY2015	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9000000	USD
CY2016	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9000000	USD
CY2015Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	191000000	USD
CY2016Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	195000000	USD
CY2015Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	20000000	USD
CY2016Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	8000000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	963000000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	696000000	USD
CY2016	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2015	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	184000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1433000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1630000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	17817000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1220000000	USD
CY2014	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2015	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-3123000000	USD
CY2016	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	53000000	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	67000000	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	17000000	USD
CY2014	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	76000000	USD
CY2015	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2016	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1492000000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13000000	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	199000000	USD
CY2014	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	19000000	USD
CY2015	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	8000000	USD
CY2016	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	3000000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17000000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33000000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	880000000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-288000000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-2408000000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2626000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2508000000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1442000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1312000000	USD
CY2015Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	27000000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2687000000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2517000000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3888000000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2055000000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2436000000	USD
CY2014	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	28000000	USD
CY2015	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	8000000	USD
CY2016	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3000000	USD
CY2016Q2	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.15
CY2014	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	246000000	USD
CY2015	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	334000000	USD
CY2016	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	421000000	USD
CY2014	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	20000000	USD
CY2015	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	106000000	USD
CY2016	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	34000000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	382000000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	132000000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	362000000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5129000000	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	61000000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	38000000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2750000000	USD
CY2014	us-gaap	Revenues Revenues	8206000000	USD
CY2015Q1	us-gaap	Revenues Revenues	2169000000	USD
CY2015Q2	us-gaap	Revenues Revenues	2733000000	USD
CY2015Q3	us-gaap	Revenues Revenues	2787000000	USD
CY2015Q4	us-gaap	Revenues Revenues	2758000000	USD
CY2015	us-gaap	Revenues Revenues	10447000000	USD
CY2016Q1	us-gaap	Revenues Revenues	2372000000	USD
CY2016Q2	us-gaap	Revenues Revenues	2420000000	USD
CY2016Q3	us-gaap	Revenues Revenues	2479000000	USD
CY2016Q4	us-gaap	Revenues Revenues	2403000000	USD
CY2016	us-gaap	Revenues Revenues	9674000000	USD
CY2014	us-gaap	Royalty Revenue RoyaltyRevenue	160000000	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	155000000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	138000000	USD
CY2015Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	37000000	USD
CY2016Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	27000000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8046000000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10292000000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	9536000000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2026000000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2700000000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2810000000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	78000000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	140000000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	165000000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2015Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	16000000	USD
CY2016Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	6000000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7286432	shares
CY2015Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1450000000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1482000000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16000000	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30000000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	33000000	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	72000000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	5910000000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	3152000000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5232000000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5401000000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6029000000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3258000000	USD
CY2016	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	75000000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	248000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	345000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	344000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	39000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	423000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	51000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	20000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	46000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	39000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	7000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	7000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	143000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	16000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	13000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	23000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	96000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	8000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	5000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	13000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	127000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	185000000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	507000000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	491000000	USD
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341500000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	342700000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	347300000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335400000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	342700000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	347300000	shares
CY2015Q4	vrx	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	17000000	USD
CY2016Q4	vrx	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	17000000	USD
CY2015Q4	vrx	Accrued Product Rebate Current AccruedProductRebateCurrent	902000000	USD
CY2016Q4	vrx	Accrued Product Rebate Current AccruedProductRebateCurrent	897000000	USD
CY2015Q4	vrx	Accrued Product Return Current AccruedProductReturnCurrent	626000000	USD
CY2016Q4	vrx	Accrued Product Return Current AccruedProductReturnCurrent	708000000	USD
CY2014	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	27000000	USD
CY2015	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	134000000	USD
CY2016	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	38000000	USD
CY2015Q2	vrx	Allocated Sharebase Compensation Expense Reversal AllocatedSharebaseCompensationExpenseReversal	6000000	USD
CY2015	vrx	Allocated Sharebased Compensation Expense Relatedto Modified Awards AllocatedSharebasedCompensationExpenseRelatedtoModifiedAwards	12000000	USD
CY2014	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	81000000	USD
CY2015	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	115000000	USD
CY2016	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	174000000	USD
CY2014	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1427000000	USD
CY2015	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2257000000	USD
CY2016	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2673000000	USD
CY2015Q4	vrx	Assumed Accrued Professional Feels Legal Liabilities AssumedAccruedProfessionalFeelsLegalLiabilities	315000000	USD
CY2015	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	130000000	USD
CY2014	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	2000000	USD
CY2016Q4	vrx	Assumed Accrued Professional Feels Legal Liabilities AssumedAccruedProfessionalFeelsLegalLiabilities	281000000	USD
CY2014	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	20000000	USD
CY2015	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	35000000	USD
CY2014	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-14000000	USD
CY2015	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-23000000	USD
CY2016	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-13000000	USD
CY2015Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	959000000	USD
CY2016Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	840000000	USD
CY2014Q3	vrx	Collaborative Agreement Milestone Payment Period CollaborativeAgreementMilestonePaymentPeriod	P5Y
CY2016Q4	vrx	Collaborative Agreement Milestone Payments Aggregate CollaborativeAgreementMilestonePaymentsAggregate	1040000000	USD
CY2015Q4	vrx	Collaborative Agreement Milestone Payments Due CollaborativeAgreementMilestonePaymentsDue	49000000	USD
CY2016Q4	vrx	Collaborative Agreement Milestone Payments Due CollaborativeAgreementMilestonePaymentsDue	12000000	USD
CY2014Q3	vrx	Collaborative Agreement Milestone Payments Due Potential CollaborativeAgreementMilestonePaymentsDuePotential	50000000	USD
CY2016	vrx	Concentration Risk Percentageof Net Trade Receivables ConcentrationRiskPercentageofNetTradeReceivables	0.40
CY2014	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	4000000	USD
CY2015	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-160000000	USD
CY2016	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-236000000	USD
CY2015Q4	vrx	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	525000000	USD
CY2016Q4	vrx	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	391000000	USD
CY2015Q4	vrx	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	51000000	USD
CY2016Q4	vrx	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	53000000	USD
CY2015Q4	vrx	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	134000000	USD
CY2016Q4	vrx	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	129000000	USD
CY2015Q4	vrx	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	1440000000	USD
CY2016Q4	vrx	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	1328000000	USD
CY2015Q4	vrx	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	16000000	USD
CY2016Q4	vrx	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	24000000	USD
CY2015Q4	vrx	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	96000000	USD
CY2016Q4	vrx	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	80000000	USD
CY2016	vrx	Defined Benefit Plan Actuarial Gain Loss Amortization Threshold Percentage DefinedBenefitPlanActuarialGainLossAmortizationThresholdPercentage	0.1
CY2016	vrx	Defined Benefit Plan Employer Contribution Maximum Age DefinedBenefitPlanEmployerContributionMaximumAge	P65Y
CY2016	vrx	Defined Benefit Plan Estimated Future Benefit Payments Period DefinedBenefitPlanEstimatedFutureBenefitPaymentsPeriod	P10Y
CY2014	vrx	Effective Income Tax Rate Reconciliation Fees Paid Amount EffectiveIncomeTaxRateReconciliationFeesPaidAmount	3000000	USD
CY2015	vrx	Effective Income Tax Rate Reconciliation Fees Paid Amount EffectiveIncomeTaxRateReconciliationFeesPaidAmount	16000000	USD
CY2016	vrx	Effective Income Tax Rate Reconciliation Fees Paid Amount EffectiveIncomeTaxRateReconciliationFeesPaidAmount	15000000	USD
CY2014	vrx	Effective Income Tax Rate Reconciliation Intra Entity Transfers Includedin Foreign Tax Rate Difference EffectiveIncomeTaxRateReconciliationIntraEntityTransfersIncludedinForeignTaxRateDifference	273000000	USD
CY2016Q4	vrx	Estimated Unrecognized Tax Benefits Realized In Next Twelve Months EstimatedUnrecognizedTaxBenefitsRealizedInNextTwelveMonths	0	USD
CY2015	vrx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Release From Restricted Cash FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReleaseFromRestrictedCash	4000000	USD
CY2016	vrx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Release From Restricted Cash FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReleaseFromRestrictedCash	0	USD
CY2015	vrx	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Adjustments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustments	0	USD
CY2016	vrx	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Adjustments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustments	10000000	USD
CY2015	vrx	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Reclassificationto Held For Sale FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationtoHeldForSale	0	USD
CY2016	vrx	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Reclassificationto Held For Sale FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationtoHeldForSale	26000000	USD
CY2014	vrx	Gain Losson Acquisitionrelated Contingent Consideration GainLossonAcquisitionrelatedContingentConsideration	14000000	USD
CY2015	vrx	Gain Losson Acquisitionrelated Contingent Consideration GainLossonAcquisitionrelatedContingentConsideration	23000000	USD
CY2016	vrx	Gain Losson Acquisitionrelated Contingent Consideration GainLossonAcquisitionrelatedContingentConsideration	13000000	USD
CY2016	vrx	Gain Losson License Agreement Termination GainLossonLicenseAgreementTermination	20000000	USD
CY2014	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	17000000	USD
CY2015	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	114000000	USD
CY2016	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	155000000	USD
CY2014	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-420000000	USD
CY2015	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-375000000	USD
CY2016	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-399000000	USD
CY2014	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	23000000	USD
CY2015	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	174000000	USD
CY2014	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	0	USD
CY2015	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	3000000	USD
CY2016	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	11000000	USD
CY2014	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	4000000	USD
CY2016	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	0	USD
CY2015	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	7000000	USD
CY2016	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	7000000	USD
CY2014	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	269000000	USD
CY2015	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	441000000	USD
CY2016	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	391000000	USD
CY2014	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-2000000	USD
CY2015	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	0	USD
CY2016	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	10000000	USD
CY2016	vrx	Maximum Term Of Original Maturity To Classify Instruments As Cash And Cash Equivalents MaximumTermOfOriginalMaturityToClassifyInstrumentsAsCashAndCashEquivalents	P3M
CY2016	vrx	Minimum Period To Classify Uncertain Tax Position Liabilities As Long Term Liabilities MinimumPeriodToClassifyUncertainTaxPositionLiabilitiesAsLongTermLiabilities	P1Y
CY2014	vrx	Noncash Or Part Noncash Acquisition Contingentand Deferred Consideration Obligations NoncashOrPartNoncashAcquisitionContingentandDeferredConsiderationObligations	133000000	USD
CY2015	vrx	Noncash Or Part Noncash Acquisition Contingentand Deferred Consideration Obligations NoncashOrPartNoncashAcquisitionContingentandDeferredConsiderationObligations	1696000000	USD
CY2016	vrx	Noncash Or Part Noncash Acquisition Contingentand Deferred Consideration Obligations NoncashOrPartNoncashAcquisitionContingentandDeferredConsiderationObligations	0	USD
CY2014	vrx	Other Comprehensive Income Loss Foreign Currency Transactionand Translation Adjustmentand Availableforsale Securities Adjustment Netof Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionandTranslationAdjustmentandAvailableforsaleSecuritiesAdjustmentNetofTax	-718000000	USD
CY2015	vrx	Other Comprehensive Income Loss Foreign Currency Transactionand Translation Adjustmentand Availableforsale Securities Adjustment Netof Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionandTranslationAdjustmentandAvailableforsaleSecuritiesAdjustmentNetofTax	-647000000	USD
CY2016	vrx	Other Comprehensive Income Loss Foreign Currency Transactionand Translation Adjustmentand Availableforsale Securities Adjustment Netof Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionandTranslationAdjustmentandAvailableforsaleSecuritiesAdjustmentNetofTax	-548000000	USD
CY2014	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-1000000	USD
CY2015	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-3000000	USD
CY2016	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-1000000	USD
CY2014	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	51000000	USD
CY2015	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
CY2016	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
CY2014	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	51000000	USD
CY2015	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2016	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2014	vrx	Other Income Expense Net OtherIncomeExpenseNet	0	USD
CY2015	vrx	Other Income Expense Net OtherIncomeExpenseNet	28000000	USD
CY2016	vrx	Other Income Expense Net OtherIncomeExpenseNet	18000000	USD
CY2014	vrx	Other Post Business Combination Acquisition Related Costs OtherPostBusinessCombinationAcquisitionRelatedCosts	27000000	USD
CY2015	vrx	Other Post Business Combination Acquisition Related Costs OtherPostBusinessCombinationAcquisitionRelatedCosts	183000000	USD
CY2016	vrx	Other Post Business Combination Acquisition Related Costs OtherPostBusinessCombinationAcquisitionRelatedCosts	0	USD
CY2014	vrx	Other Post Business Combination Acquisition Related Costs Accelerationof Unvested Restricted Stock OtherPostBusinessCombinationAcquisitionRelatedCostsAccelerationofUnvestedRestrictedStock	20000000	USD
CY2015	vrx	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2016	vrx	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2014	vrx	Paymentof Deferred Consideration PaymentofDeferredConsideration	0	USD
CY2015	vrx	Paymentof Deferred Consideration PaymentofDeferredConsideration	55000000	USD
CY2016	vrx	Paymentof Deferred Consideration PaymentofDeferredConsideration	540000000	USD
CY2016	vrx	Period Receivable Outstanding PeriodReceivableOutstanding	P90D
CY2015	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	348800000	shares
CY2016	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	350100000	shares
CY2015Q1	vrx	Saleof Stock Public Offering Price Per Share SaleofStockPublicOfferingPricePerShare	199.00
CY2015Q1	vrx	Sharebased Compensation Arrangementby Sharebased Payment Award Additional Purchase Optionasa Percentageof Shares Issuedin Ipo Maximum SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalPurchaseOptionasaPercentageofSharesIssuedinIPOMaximum	0.15
CY2014	vrx	Stock Issued During Period Value Equity Settlement And Reclassification Of Call Options StockIssuedDuringPeriodValueEquitySettlementAndReclassificationOfCallOptions	-3000000	USD
CY2016	vrx	Tax Benefit Recognition Measurement Percentage TaxBenefitRecognitionMeasurementPercentage	0.5
CY2015	vrx	Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions	-21000000	USD
CY2016	vrx	Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions	63000000	USD
CY2015Q4	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	344000000	USD
CY2016Q4	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	423000000	USD
CY2015	vrx	Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions	5000000	USD
CY2016	vrx	Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions	16000000	USD
CY2016Q4	vrx	Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate	238000000	USD
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and trade receivables.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash in high-quality, money market instruments and term deposits with varying maturities, but typically less than </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">The Company’s cash and cash equivalents are invested in various investment grade institutional money market accounts and bank term deposits. Deposits held at banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate such risks by spreading its risk across multiple counterparties and monitoring the risk profiles of these counterparties.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s trade receivables primarily represent amounts due from wholesale distributors, retail pharmacies, government entities and group purchasing organizations. Outside of the U.S., concentrations of credit risk with respect to trade receivables, which are typically unsecured, are limited due to the number of customers using the Company’s products, as well as their dispersion across many different geographic regions. The Company performs periodic credit evaluations of customers and does not require collateral. The Company monitors economic conditions, including volatility associated with international economies, and related impacts on the relevant financial markets and its business, especially in light of sovereign credit issues. The credit and economic conditions within Italy, Portugal, Spain, Greece, among other members of the European Union, Russia, Brazil, and Egypt have been weak in recent years. In November 2016, as a result of the Egyptian government’s decision to float the Egyptian pound and un-peg it to the U.S. Dollar, the Egyptian pound was significantly devalued.  The Company's exposure to the Egyptian pound is primarily with respect to the Amoun Pharmaceutical Company S.A.E. business acquired in October 2015, which represented approximately </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-family:inherit;font-size:10pt;"> of the Company's 2016 total revenues. These conditions have increased, and may continue to increase, the average length of time that it takes to collect on the Company’s trade receivables outstanding in these countries. An allowance for doubtful accounts is maintained for potential credit losses based on the aging of trade receivables, historical bad debts experience, and changes in customer payment patterns. Trade receivable balances are written off against the allowance when it is deemed probable that the receivable will not be collected.</font></div></div>
CY2016	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valeant Pharmaceuticals International, Inc. (the “Company”) is a multinational, specialty pharmaceutical and medical device company that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries. Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 1, 2015, the Company acquired Salix Pharmaceuticals, Ltd. (“Salix”), pursuant to an Agreement and Plan of Merger dated February 20, 2015, as amended on March 16, 2015 (the “Salix Merger Agreement”), with Salix surviving as a wholly owned subsidiary of Valeant Pharmaceuticals International (“Valeant”), a subsidiary of the Company (the “Salix Acquisition”). See Note 3 for additional information regarding the Salix Acquisition and related financing.</font></div></div>
CY2016	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform to the current year presentation. </font></div></div>
CY2016	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Sales </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes product sales revenue when persuasive evidence of an arrangement exists, delivery has occurred, collectability is reasonably assured, and the price to the buyer is fixed or determinable, the timing of which is based on the specific contractual terms with each customer. Delivery occurs when title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. As such, the Company generally recognizes revenue on a sell-in basis (i.e., record revenue upon delivery); however, based upon specific terms and circumstances, the Company has determined that, for certain arrangements with certain retailers and other third parties, revenue should be recognized on a sell-through basis (i.e., record revenue when products are dispensed to patients). In evaluating the proper revenue recognition for sales transactions, the Company considers all relevant factors, including additional discounts or extended payment terms which the Company grants to certain customers, often near the end of fiscal quarterly periods.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from product sales is recognized net of provisions for estimated cash discounts, allowances, returns, rebates, chargebacks and distribution fees paid to certain of the Company’s wholesale customers. The Company establishes these provisions concurrently with the recognition of product sales revenue.  Price appreciation credits are generated when the Company increases a product’s wholesaler acquisition cost (“WAC”) under its contracts with certain wholesalers. Under such contracts, the Company is entitled to credits from such wholesalers for the impact of that WAC increase on inventory currently on hand at the wholesalers. Such credits, which can be significant, are used to offset against the total distribution service fees the Company pays on all of its products to each wholesaler. Net revenue on these credits is recognized on the date that the wholesaler is notified of the price increase. The Company offers cash discounts for prompt payment and allowances for volume purchases to customers. Provisions for cash discounts and allowances are estimated based on contractual sales terms with customers, an analysis of unpaid invoices, and historical payment experience. The Company generally allows customers to return product within a specified period of time before and after its expiration date, excluding the Company’s European businesses which generally do not carry a right of return. Provisions for returns are estimated based on historical sales and return levels, taking into account additional available information such as historical return and exchange levels, external data with respect to inventory levels in the wholesale distribution channel, external data with respect to prescription demand for the Company’s products, remaining shelf lives of the Company’s products at the date of sale and estimated returns liability to be processed by year of sale based on analysis of lot information related to actual historical returns. The Company reviews its methodology and adequacy of the provision for returns on a quarterly basis, adjusting for changes in assumptions, historical results and business practices, as necessary. The Company is subject to rebates on sales made under governmental and managed-care programs in the U.S., and chargebacks on sales made to government agencies, group purchasing organizations and other indirect customers. Provisions for rebates and chargebacks are estimated based on historical utilization levels, relevant statutes with respect to governmental pricing programs and contractual sales terms with managed-care providers and group purchasing organizations. Changes in the level of utilization of the Company’s products through private or public benefit plans and group purchasing organizations will impact the amount of rebates and chargebacks that the Company is obligated to pay.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is party to product manufacturing and supply agreements with a number of commercialization counterparties in the U.S. Under the terms of these agreements, the Company’s supply prices for its products are determined after taking into consideration estimates for future returns, rebates, and chargebacks provided by each counterparty. The Company makes adjustments as needed to state these estimates on a basis consistent with this policy and its methodology for estimating returns, rebates and chargebacks related to its own direct product sales.</font></div></div>

Files In Submission

Name	View Source	Status
0000885590-17-000015-index-headers.html	Edgar Link	pending
0000885590-17-000015-index.html	Edgar Link	pending
0000885590-17-000015.txt	Edgar Link	pending
0000885590-17-000015-xbrl.zip	Edgar Link	pending
a2016performancegraph.jpg	Edgar Link	pending
d343902dex1017.htm	Edgar Link	pending
d343902dex1018.htm	Edgar Link	pending
d343902dex1019.htm	Edgar Link	pending
d343902dex1023.htm	Edgar Link	pending
d343902dex1030.htm	Edgar Link	pending
d343902dex1031.htm	Edgar Link	pending
d343902dex1033.htm	Edgar Link	pending
d343902dex1035.htm	Edgar Link	pending
d343902dex1036.htm	Edgar Link	pending
d343902dex1038.htm	Edgar Link	pending
exhibit2112016ye.htm	Edgar Link	pending
exhibit2312016ye.htm	Edgar Link	pending
exhibit3112016ye.htm	Edgar Link	pending
exhibit3122016ye.htm	Edgar Link	pending
exhibit3212016ye.htm	Edgar Link	pending
exhibit3222016ye.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g34390201.jpg	Edgar Link	pending
g34390202.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
valeant10k-exhibit10_16psu.htm	Edgar Link	pending
valeant2016form10-k.htm	Edgar Link	pending
vrx-20161231.xml	Edgar Link	completed
vrx-20161231.xsd	Edgar Link	pending
vrx-20161231_cal.xml	Edgar Link	unprocessable
vrx-20161231_def.xml	Edgar Link	unprocessable
vrx-20161231_lab.xml	Edgar Link	unprocessable
vrx-20161231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2015 Q4 Form 10-K Financial Statement

#000088559017000015 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2015 Q4 Form 10-K Financial Statement

#000088559017000015 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc